OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
May 15, 2014
A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.
What is a modular system and how are modular systems being used in the biopharmaceutical industry? Pär
Application of single-use technology in a parenteral facility for syringe filling.
May 14, 2014
An interview with Doug Hausner, C-SOPS, about continuous manufacturing
Draft guidance addresses the use of clinical pharmacology studies to determine biosimilarity of biologics.
Catalent's Advasept platform uses blow-fill-seal technology to aseptically manufacture, fill, and seal a polymeric primary container for injectable drugs.
May 12, 2014
The ionHP biodecontamination hydrogen peroxide-based sterilization technology is designed for use in aseptic enclosures.
May 08, 2014
The Manesty TPR 500 tablet press from Bosch Packaging Technology increases output and features a hygienic design.
May 02, 2014
New formulations and expanded vaccine production are encouraged.
May 01, 2014
Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.